Article

Outrage at the Increasingly High Cost of Cancer Drugs

Cancer drug prices have doubled in the past decade, from an average of $5,000 per month to more than $10,000.

Cancer drug prices have doubled in the past decade, from an average of $5,000 per month to more than $10,000.

Eleven of the 12 cancer drugs the Food and Drug Administration approved for fighting cancer in 2012 were priced at more than $100,000 per year, double the average annual household income, according to a report by the Journal of National Cancer Institute.

Patricia Thomson, a married, working mother whose leukemia is in remission, is one of the many cancer patients struggling to pay for her medication.

One of her prescriptions, Sprycel, is helping to keep her alive but it costs at least $106,000 a year. Even with Medicare payments, Thomson would have to pay about $10,000 a year out of pocket.

Read the full story here: http://abcn.ws/1ho6QHb

Source: ABC News

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
4 experts are featured in this series.
5 experts are featured in this series
5 experts are featured in this series
4 experts are featured in this series.
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Raj Chovatiya, MD, PhD, MSCI.
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
4 experts are featured in this series.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo